NasdaqCM - Delayed Quote • USD
Moleculin Biotech, Inc. (MBRX)
At close: April 26 at 4:00 PM EDT
After hours: April 26 at 7:03 PM EDT
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Expense
29,631.0000
29,631.0000
30,640.0000
22,968.0000
19,742.0000
Operating Income
-29,631.0000
-29,631.0000
-30,640.0000
-22,968.0000
-19,742.0000
Net Non Operating Interest Income Expense
1,368.0000
1,368.0000
240.0000
306.0000
13.0000
Other Income Expense
-1,506.0000
-1,506.0000
1,375.0000
6,768.0000
2,374.0000
Pretax Income
-29,769.0000
-29,769.0000
-29,025.0000
-15,894.0000
-17,355.0000
Net Income Common Stockholders
-29,769.0000
-29,769.0000
-29,025.0000
-15,894.0000
-17,355.0000
Diluted NI Available to Com Stockholders
-29,769.0000
-29,769.0000
-29,025.0000
-15,894.0000
-17,355.0000
Basic EPS
-15.15
--
-15.30
-8.85
-26.40
Diluted EPS
-15.15
--
-15.30
-8.85
-26.40
Basic Average Shares
1,965.7810
--
1,897.4720
1,791.7280
656.3790
Diluted Average Shares
1,965.7810
--
1,897.4720
1,791.7280
656.3790
Total Operating Income as Reported
-29,631.0000
-29,631.0000
-30,640.0000
-22,968.0000
-19,742.0000
Total Expenses
29,631.0000
29,631.0000
30,640.0000
22,968.0000
19,742.0000
Net Income from Continuing & Discontinued Operation
-29,769.0000
-29,769.0000
-29,025.0000
-15,894.0000
-17,355.0000
Normalized Income
-28,725.0000
-28,725.0000
-30,360.0000
-22,622.0000
-19,701.0000
Interest Income
1,368.0000
1,368.0000
240.0000
306.0000
13.0000
Net Interest Income
1,368.0000
1,368.0000
240.0000
306.0000
13.0000
EBIT
-29,631.0000
-29,631.0000
-30,640.0000
-22,968.0000
-19,742.0000
EBITDA
-29,504.0000
-29,504.0000
-30,510.0000
-22,804.0000
-19,542.0000
Reconciled Depreciation
127.0000
127.0000
130.0000
164.0000
200.0000
Net Income from Continuing Operation Net Minority Interest
-29,769.0000
-29,769.0000
-29,025.0000
-15,894.0000
-17,355.0000
Total Unusual Items Excluding Goodwill
-1,044.0000
-1,044.0000
1,335.0000
6,728.0000
2,346.0000
Total Unusual Items
-1,044.0000
-1,044.0000
1,335.0000
6,728.0000
2,346.0000
Normalized EBITDA
-28,460.0000
-28,460.0000
-31,845.0000
-29,532.0000
-21,888.0000
12/31/2020 - 6/2/2016
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
ALRN Aileron Therapeutics, Inc.
5.0000
-1.19%
PULM Pulmatrix, Inc.
2.0400
-1.45%
CNSP CNS Pharmaceuticals, Inc.
0.2150
+2.87%
SNGX Soligenix, Inc.
0.4150
-2.81%
PPBT Purple Biotech Ltd
0.4900
-2.00%
NEXI NexImmune, Inc.
3.3700
-1.17%
TENX Tenax Therapeutics, Inc.
3.4800
-0.85%
CAPR Capricor Therapeutics, Inc.
5.41
+5.05%
TCON TRACON Pharmaceuticals, Inc.
1.8100
+1.12%
RNAC Cartesian Therapeutics, Inc.
21.03
+0.62%